Home » dr reddys laboratories

You Searched For "Dr Reddy’s Laboratories"

According to the US FDA guidelines, a recall under Class-III classification would mean the use of such drug may not cause adverse health consequences. (Photo: AFP)

Dr Reddy's Laboratories drug fails tests, recalled

this is the third product recall by Dr Reddy's Labs in 2017 due to quality issues.

21 Oct 2017 4:03 AM IST

WhatsApp is of the most popular messaging platforms for sharing information. Random news is known for spreading rumours and scams.

Whatsapp groups get info before bourses

Select traders get information about some companies, including DRL, before official announcement.

17 Nov 2017 1:22 AM IST

According to the US FDA guidelines, a recall under Class-III classification would mean the use of such drug may not cause adverse health consequences. (Photo: AFP)

DRL profit drops by 29 per cent in Q3

DRL is one of the several companies that have been facing heat in its key US market.

26 Jan 2018 12:31 AM IST

These batches are now back on the retail shelves in that country. Meanwhile, Dr Reddys Laboratories have recalled all its ranitidine medications in the US.

Strides' ranitidine gets Oz nod

On 13 September, the US FDA had issued a safety alert citing traces of NDMA in ranitidine.

24 Oct 2019 1:31 AM IST

The value of total addressable market for these products in the US is around USD 645 million for the calendar year ending in December 2018.

Dr Reddy's acquires a portfolio of 42 abbreviated new drug...

The company said it has entered into a definitive agreement to acquire yet to be marketed portfolio of ANDAs.

14 April 2019 1:15 PM IST

Dr Reddys said it will receive sales-based royalties on a quarterly basis.

Dr Reddy's to sell 2 neurology branded products to Upsher-Smith Labs...

Under the agreement, Dr Reddy's will receive USD 70 million as upfront consideration, USD 40.5 million in near-term...

14 Jun 2019 11:44 AM IST

Dr Reddys said it will receive sales-based royalties on a quarterly basis.

Brokerages bullish on DRL

The net profit grew 30.62 per cent YoY to Rs 521.70 crore from Rs 399.40 crore the same quarter last year.

30 Jan 2020 1:36 AM IST

Fujifilm to partner with Dr. Reddys to sell Avigan overseas as COVID-19 treatment. (PTI Photo)

Fujifilm partners with Dr Reddy's to sell Avigan for COVID-19...

In June, Glenmark received regulatory approval for favipiravir, generic form of Avigan, as treatment for virus...

1 July 2020 2:55 PM IST

A Russian medical worker adminsters a shot of Russias experimental Sputnik V coronavirus vaccine in Moscow, Russia. Russian health authorities have launched advanced trials of the vaccine among 40,000 volunteers, a randomized, placebo-controlled study. (AP)

Russia seals deal to supply and test its coronavirus vaccine in India

Dr Reddy's, one of India's top pharmaceutical companies, will carry out Phase III clinical trials of Sputnik-V in India,...

17 Sept 2020 10:15 AM IST

A health worker holds a vial of the Sputnik V vaccine against COVID-19 while Charles Chaplins movies are projected at the Lumiere movie theater, used as vaccination center, in Rosario, Santa Fe province, Argentina, on March 26, 2021. (Marcelo Manera / AFP)

'Dr Reddy's expects Sputnik V vaccine to get approval from Indian...

Dr Reddy's has partnered with the Russia Direct Investment Fund to bring the Sputnik V vaccine to India and other...

29 March 2021 2:18 PM IST

2-DG manufactured by Dr. Reddys has a purity of 99.5 per cent. (Photo: Twitter/@drreddys)

Dr. Reddy's Labs to launch Covid drug 2-DG at Rs 990 per sachet

The company will make the drug available in hospitals across metros and Tier 1 cities in the initial weeks

28 Jun 2021 1:50 PM IST

A medical worker holds a vial of Russias Sputnik V vaccine for Covid-19. (Photo:AP/File)

Dr Reddy's denied approval for Phase 3 trials of Sputnik Light Covid...

After launching Sputnik V, Russia had introduced a new single-dose vaccine called Sputnik Light in May

1 July 2021 12:07 PM IST